A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN)

Psycho-Oncology

Volumn 24, Issue 9, 2015, Pages 1159-1166

  Stefanopoulou, Evgenia ^a   Yousaf, Omar ^a,c   Grunfeld, Elizabeth A ^b   Hunter, Myra S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Faculty of Engineering and Computing   (United Kingdom)

^c University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; CYPROTERONE ACETATE; GOSERELIN; LEUPRORELIN; TRIPTORELIN; ANTIANDROGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOT FLUSH; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOOD; NIGHT SWEAT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF HELP; SELF REPORT; TREATMENT AS USUAL; AFFECT; ATTITUDE TO HEALTH; CHEMICALLY INDUCED; HOT FLASHES; MIDDLE AGED; PROCEDURES; PROSTATIC NEOPLASMS; PSYCHOLOGY; SHORT TERM PSYCHOTHERAPY; SWEATING; TREATMENT OUTCOME;

AFFECT; AGED; ANDROGEN ANTAGONISTS; COGNITIVE THERAPY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOT FLASHES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PSYCHOTHERAPY, BRIEF; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; SWEATING; TREATMENT OUTCOME;

EID: 84941182767     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3794     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA: A Cancer J Clin 2011; 61 (2): 69-90.
2. Graham J, Baker M, Macbeth F, et al., Guidelines: diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ 2008; 336 (7644): 610-612.
3. Grunfeld EA, Halliday A, Martin P, et al., Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms. Cancer Nurs. 2013; 35 (1): 63-69.
4. Frisk J., Managing hot flushes in men after prostate cancer. A systematic review. Maturitas 2010; 65 (1): 15-22.
5. Fisher WI, Johnson AK, Elkins GR, et al., Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA: A Cancer J Clin 2013; 63 (3): 167-192.
6. Hanisch LJ, Gooneratne NS, Soin K, et al., Sleep and daily functioning during androgen deprivation therapy for prostate cancer. Europ J Cancer Care 2011; 20 (4): 549-554.
7. Nishiyama T, Kanazawa S, Watanabe R, et al., Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy. Intern J Urol 2004; 11 (9): 735-741.
8. Spetz A-C, Zetterlund E-L, Varenhorst E, et al., Incidence and management of hot flashes in prostate cancer. J. Support. Oncol. 2001; 1 (4): 263-272.
9. Ulloa EW, Salup R, Patterson SG, et al., Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer. Psycho-Oncology 2009; 18 (6): 598-605.
10. Baum N, Torti D,. Management of hot flashes in men with prostate cancer. Geriat Aging 2003; 6 (2): 43-46.
11. Siegel R, Naishadham D, Jemal A,. Cancer statistics. CA: A Cancer J Clin 2013; 63 (1): 11-30.
12. Ayers B, Smith M, Hellier J, et al., Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause 2012; 19 (7): 749-759.
13. Mann E, Smith MJ, Hellier J, et al., Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012; 13 (3): 309-318.
14. Duijts SF, van Beurden M, Oldenburg HS, et al., Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J. Clin. Oncol. 2012; 30 (33): 4124-4133.
15. Stefanopoulou E, Hunter MS,. Telephone-guided self-help cognitive behavioural therapy for menopausal symptoms. Maturitas 2014; 77 (1): 73-77.
16. Hunter MS, Mann E,. A cognitive model of menopausal hot flushes and night sweats. J. Psychosom. Res. 2010; 69 (5): 491-501.
17. Ayers B, Hunter MS,. Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 2013; 16: 235-239.
18. Rand K, Otte J, Flockhart D, et al., Modeling hot flushes and quality of life in breast cancer survivors. Climacteric 2011; 14: 171-180.
19. Hanisch LJ, Palmer SC, Donahue A, et al., Validation of sternal skin conductance for detection of hot flashes in prostate cancer survivors. Psychophysiol 2007; 44 (2): 189-193.
20. Yousaf O, Stefanopoulou E, Grunfeld E, et al., A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): trial protocol. BMC Cancer 2012; 12 (1): 1-7.
21. Hunter MS, Liao KL-M,. A psychological analysis of menopausal hot flushes. Brit J Clin Psychol 1995; 34 (4): 589-599.
22. Hunter MS,. Cognitive behavioural interventions for the treatment of menopausal symptoms. Expert Rev Obstet Gynaecol 2012; 7 (4): 321-326.
23. Hunter MS, Chilcot J,. Testing a cognitive model of menopausal hot flushes and night sweats. J. Psychosom. Res. 2013 74 (4): 307-312.
24. Eziefula C, Grunfeld E, Hunter MS,. You know I've joined your club I'm the hot flush boy: a qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer. Psycho-Oncology 2013; 22 (12): 2823-2830.
25. Beecham J, Knapp M,. In Measuring Mental Health Needs, Thornicroft G, (ed.), Costing psychiatric interventions. Gaskell: London, UK, 2001; 200-224.
26. Zigmond AS, Snaith RP,. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand 1983; 67 (6): 361-370.
27. Fayers P, Bottomley A,. Quality of life research within the EORTC-the EORTC QLQ-C30. Europ J Cancer 2002; 38: 125-133.
28. van Andel G, Bottomley A, Fosså SD, et al., An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Europ J Cancer 2008; 44 (16): 2418-2424.
29. Fife BL,. The role of constructed meaning in adaptation to the onset of life-threatening illness. Soc. Sci. Med. 2005; 61 (10): 2132-2143.
30. Mansfield AK, Addis ME, Courtenay W,. Measurement of men's help seeking: development and evaluation of the barriers to help seeking scale. Psychol Men & Masculinity 2005; 6 (2): 95-108.
31. Barsky AJ, Wyshak G, Klerman GL,. The Somatosensory Amplification Scale and its relationship to hypochondriasis. J. Psychiatr. Res. 1990; 24 (4): 323-334.
32. Herzberg PY, Glaesmer H, Hoyer J,. Separating optimism and pessimism: a robust psychometric analysis of the Revised Life Orientation Test (LOT-R). Psychol. Assess. 2006; 18 (4): 433-438.
33. Hunter MS, Sharpley CF, Stefanopoulou E, et al., The hot flush beliefs and behaviour scale for men (HFBBS-Men) undergoing treatment for prostate cancer. Maturitas 2014; 79: 464-470.
34. Bahr DE, Webster JG, Grady D, D Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events. Physiol Measurement 2014; 35 (2):95.
35. Stefanopoulou E, Hunter MS,. Does pattern recognition software using the Bahr monitor improve the sensitivity, specificity, and concordance of ambulatory skin conductance monitoring of hot flushes? Menopause 2013; 20 (11): 1-6.
36. Irani J, Salomon L, Oba R, et al., Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol. 2010; 11 (2): 147-154.
37. Hanisch LJ, Palmer S, Marcus S, et al., Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J. Support. Oncol. 2009; 7 (4): 1-5.
38. Watts S, Leydon G, Birch B, et al., Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 2014; 4: 1-9. DOI: 10.1136/bmjopen-2013-003901.
39. Fayers PM, Weeden S, Curran D, on behalf of the EORTC Quality of Life Study Group. EORTC QLQ-C30 Reference Values. Brussels, EORTC, 1998.
40. Chilcot J, Norton S, Hunter MS,. Cognitive behaviour therapy for menopausal symptoms following breast cancer treatment: who benefits and how does it work? Maturitas 2014; 78 (1): 56-61.